1 dose before age 12 mos 2 doses, 8 weeks apart ≥ 1 dose, 8 after the most ≥ 1 dose at mos ≥12 recent dose 2 1 dose, 8 after the most ≥ 2 or 3 doses before age 12 mos recent dose 2 4 doses of PCV7 or other 1 supplemental dose, 8 weeks ≥ complete PCV7 after the most recent dose * schedule 1 dose, 8 weeks after the most ≥ Any incomplete schedule recent dose 2 Healthy children 24 months through 1 supplemental dose, 8 weeks 4 of PCV7 or other ≥ 59 months after the most recent dose of age-appropriate, complete PCV7 PCV7 vaccine* schedule TABLE 2. Recommended schedules for administering doses of PCV13 among children who have not previously received PCV7 or PCV13 and those incompletely vaccinated with PCV7 or PCV13 for age and supplemental PCV13 immunization ; updated with Vaccination history: total Recommended PCV13 Age number of PCV7 and/or PCV13 Regimen1 doses received previously 2 one 8 weeks after the ≥ Children Any incomplete schedule of most recent dose and another 24 months through <2 doses dose 8 weeks later ≥ 71 months with underlying medical Any incomplete schedule of 1 dose, 8 weeks after the most ≥ conditions as 3 doses recent dose
1 dose before age 12 mos 2 doses, ≥ 8 weeks apart 1 dose at ≥12 mos 1 dose, ≥ 8 after the most recent dose 2 2 or 3 doses before age 12 mos 1 dose, ≥ 8 after the most recent dose 2 4 doses of PCV7 or other complete PCV7 schedule 1 supplemental dose, ≥ 8 weeks after the most recent dose * Healthy children 24 months through 59 months Any incomplete schedule 1 dose, ≥ 8 weeks after the most recent dose 2 4 of PCV7 or other age-appropriate, complete PCV7 schedule 1 supplemental dose, ≥ 8 weeks after the most recent dose of PCV7 vaccine* TABLE 2. Recommended schedules for administering doses of PCV13 among children who have not previously received PCV7 or PCV13 and those incompletely vaccinated with PCV7 or PCV13 for age and supplemental PCV13 immunization ; updated with Age Vaccination history: total number of PCV7 and/or PCV13 doses received previously Recommended PCV13 Regimen1 Children 24 months through 71 months with underlying medical conditions as Any incomplete schedule of <2 doses 2 one ≥ 8 weeks after the most recent dose and another dose ≥ 8 weeks later Any incomplete schedule of 3 doses 1 dose, ≥ 8 weeks after the most recent dose
2016CCSGPCV13ProtocolFINAL.docx